http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102010021514-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89e4b9091f8203fee6f9844b4750ac16 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-976 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 |
| filingDate | 2010-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_031670d94f9106f0e20ea2760c2df11a |
| publicationDate | 2010-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102010021514-A1 |
| titleOfInvention | Proteasomes as markers for therapy and drug standardization |
| abstract | Use of the determination of the proteasome activity for the standardization and testing of preparations (especially in the case of parenteral administration) which influence the immune system by testing the effect on in particular the protease activity of proteasomes in vitro, and corresponding methods; Use of the determination of the proteasome activity as a biomarker for the therapy with (in particular parenterally administered) the immune system influencing preparations, and corresponding methods and other uses, as well as the immune system affecting preparations (especially for parenteral use) for use in patients whose proteasome activity by administering the Immune system influencing preparations is modulated. |
| priorityDate | 2009-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.